Eriko Toyoda Selected Research

Eriko Toyoda Research Topics

Disease

4	Knee Osteoarthritis 12/2022 - 01/2020
4	Polydactyly (Polydactylism) 12/2022 - 01/2017
2	Osteoarthritis 03/2021 - 12/2019
2	Arthritis (Polyarthritis) 12/2018 - 11/2004
2	Pain (Aches) 11/2018 - 11/2017
2	Neoplasms (Cancer) 02/2009 - 01/2008
2	Hematuria 09/2008 - 11/2006
2	Proteinuria 09/2008 - 11/2006
2	Glomerulonephritis 09/2008 - 11/2006
2	Vitreous Hemorrhage 04/2008 - 02/2008
1	Joint Diseases (Joint Disease) 03/2021
1	Necrosis 01/2020
1	Melanoma (Melanoma, Malignant) 01/2018
1	Breast Neoplasms (Breast Cancer) 02/2009
1	Poisoning 02/2009
1	Vasculitis (Vasculitides) 09/2008
1	Hypersensitivity (Allergy) 08/2008
1	Hemorrhage 05/2008
1	Uveal Effusion Syndrome 05/2008
1	Cataract (Cataracts) 02/2008
1	Macular Edema 02/2008
1	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2006
1	Lymphadenopathy 11/2006
1	Experimental Arthritis 11/2004

Drug/Important Bio-Agent (IBA)

2	Indicators and Reagents (Reagents)IBA 11/2018 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 02/2009 - 01/2008
2	Immunosuppressive Agents (Immunosuppressants)IBA 09/2008 - 11/2006
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2008 - 11/2006
2	NK314IBA 08/2008 - 01/2008
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	CytokinesIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	Platelet-Derived Growth FactorIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	SolutionsIBA 01/2020
1	Iodoacetic AcidIBA 12/2018
1	CytidineIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	PyridoxalIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	UracilIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	IronIBA 02/2009
1	Chelating AgentsIBA 02/2009
1	di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazoneIBA 02/2009
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2009
1	Peroxidase (Myeloperoxidase)IBA 09/2008
1	Retinaldehyde (Retinal)IBA 05/2008
1	Topoisomerase II InhibitorsIBA 01/2008
1	(S)- 1- (5- hydroxy- 1,5- dimethylhexyl)- 3- (7- (4- methoxyphenyl)- (1,2,4- triazolo(1,5- a)pyrimidin- 2- yl))ureaIBA 11/2006
1	NitrogenIBA 11/2006
1	Urea (Carbamide)FDA LinkGeneric 11/2006
1	AutoantibodiesIBA 11/2006
1	Antinuclear AntibodiesIBA 11/2006
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2006
1	N- (2- (4- methoxybenzenesulfonamide)phenyl)- 3,5- dimethyl- 4- isoxazolcarboxamideIBA 11/2004
1	Methotrexate (Mexate)FDA LinkGeneric 11/2004

Therapy/Procedure

3	Therapeutics 12/2022 - 03/2021
3	Transplantation 12/2022 - 12/2018
3	Vitrectomy 05/2008 - 02/2008
1	Osteotomy 12/2022
1	Injections 03/2021
1	Light Coagulation 05/2008
1	Sclerostomy 05/2008
1	Phacoemulsification 02/2008
1	Intraocular Lens Implantation 02/2008
1	Oral Administration 11/2006